Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
November 05 2007 - 4:21PM
PR Newswire (US)
CHARLOTTE, N.C., Nov. 5 /PRNewswire-FirstCall/ -- MedCath
Corporation (NASDAQ:MDTH) announced today that Arizona Heart
Hospital, one of the 11 hospitals in which MedCath owns an
interest, has entered into a settlement with the United States
Department of Justice (the DOJ) and the United States Attorneys'
Office in Phoenix under the federal Civil False Claims Act. The
settlement concerns Medicare claims submitted between June 1998 and
October 2002 for physician services involving the implantation of
certain endoluminal graft devices (utilized to treat aneurysms)
that had not received final marketing approval from the Food and
Drug Administration, and allegedly were either implanted without an
approved investigational device exception (IDE) or were implanted
outside of the approved IDE protocol. The DOJ's allegations related
solely to whether the procedures were properly reimbursable by
Medicare; quality of patient care was not at issue. The parties
reached a settlement of the allegations to avoid the delay,
uncertainty, inconvenience, and expense of protracted litigation.
Further, the hospital denies engagement in any wrongdoing or
illegal conduct, and the settlement agreement does not contain any
admission of liability. As previously disclosed in MedCath's
filings with the Securities and Exchange Commission, the hospital
will pay approximately $5.8 million to settle and obtain a release
from any civil or administrative monetary claims related to the
DOJ's investigation. Additionally, the hospital has entered into a
five- year corporate integrity agreement with the Office of the
Inspector General of the Department of Health and Human Services
under which the hospital will continue to maintain its existing
corporate compliance program and which relates to clinical trials
conducted at the hospital. MedCath Corporation, headquartered in
Charlotte, N.C., is a healthcare provider focused on high acuity
services with the diagnosis and treatment of cardiovascular disease
being a primary service offering. MedCath owns interests in and
operates eleven hospitals with a total of 667 licensed beds,
located in Arizona, Arkansas, California, Louisiana, New Mexico,
Ohio, South Dakota, and Texas. In addition, MedCath and its
subsidiary MedCath Partners manage the cardiovascular program at
various hospitals and provide services in diagnostic and
therapeutic facilities in various states. DATASOURCE: MedCath
Corporation CONTACT: O. Edwin French, President & Chief
Executive Officer, +1-704-708-6600; or James E. Harris, Chief
Financial Officer, +1-704-708-6600, both of MedCath Corporation
Copyright
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024